Finance committee  Thank you, Mr. Chair. Perhaps I could clarify one point. Over the past year, the Government of Canada and provinces and territories have worked together on a standardized proof-of-vaccination credential, recognizing the need for citizens and residents to have access to a secure

Finance committee  We're in the process now of continuing our analysis on allocation options for the minister to consider. The objective, as I mentioned earlier, is to cover both previous costs and ongoing costs. In the context of jurisdictions that have sunset their proof-of-vaccination requiremen

Finance committee  I would not think so no.

Health committee  Mr. Chair, I would suggest that I take that question. PHAC works very closely with provinces and territories to ensure that procurement and allocation strategies align with the requirements and demands of individual jurisdictions. When there are doses surplus to Canada's need, C

Health committee  We work very closely with Global Affairs Canada and international bodies like COVAX to make doses available as soon as we can, so that they can be used if needed by other countries. We have made doses available to COVAX, and they are in the process of identifying countries that c

Health committee  I would offer that we continue to work with COVAX to identify potential countries that could take the doses, and offer as much lead time as possible.

Health committee  No, I would just echo Dr. Tam's comment that our current agreements with Moderna allow us to access new formulations when they're approved by the regulator. Thank you, Mr. Chair.

Health committee  In terms of encouraging Canadians to take the third dose as we continue to work very closely with our provincial and territorial partners in the context of communication to Canadians, Dr. Tam is out frequently reminding Canadians of the importance of keeping their vaccinations up

Health committee  Thank you. I would add that, as it was stated earlier, two doses of vaccine still offer considerable protection in terms of severe disease. Fundamentally, in the context of our objective of reducing hospitalizations, severe illness and death, two doses perform well. We know, as

Health committee  I would offer that we've consistently communicated to Canadians that vaccination is one of the most important measures to protect themselves and to protect others.

Health committee  Thank you, Dr. Tam.

Health committee  Thank you, Mr. Chair. I would only add that this year alone we've been able to invest an additional $5.3 million in projects to reach under-reached and marginalized communities, including indigenous and racialized communities. I would also add that in the context of vaccine con

Public Accounts committee  Thank you very much. In the context of vaccine donations, I think the number you're referring to is in the context of some AstraZeneca doses that we had. I think you referred to 13 million doses that expired. Those were put on offer in 2021, as soon as we were able to make them

Public Accounts committee  The 13-million dose number that you cited for AstraZeneca were the doses that were lost because they were not able to be placed. The remainder were donated to countries. To bring precision to what Dr. Kochhar mentioned in terms of the countries we were able to support both throu

Public Accounts committee  AstraZeneca vaccines. Yes.